Literature DB >> 27623089

Crystal structures of two nitroreductases from hypervirulent Clostridium difficile and functionally related interactions with the antibiotic metronidazole.

Bing Wang1, Samantha M Powell1, Neda Hessami1, Fares Z Najar1, Leonard M Thomas1, Elizabeth A Karr2, Ann H West1, George B Richter-Addo3.   

Abstract

Nitroreductases (NRs) are flavin mononucleotide (FMN)-dependent enzymes that catalyze the biotransformation of organic nitro compounds (RNO2; R = alkyl, aryl) to the nitroso RN=O, hydroxylamino RNHOH, or amine RNH2 derivatives. Metronidazole (Mtz) is a nitro-containing antibiotic that is commonly prescribed for lower-gut infections caused by the anaerobic bacterium Clostridium difficile. C. difficile infections rank number one among hospital acquired infections, and can result in diarrhea, severe colitis, or even death. Although NRs have been implicated in Mtz resistance of C. difficile, no NRs have been characterized from the hypervirulent R20291 strain of C. difficile. We report the first expression, purification, and three-dimensional X-ray crystal structures of two NRs from the C. difficile R20291 strain. The X-ray crystal structures of the two NRs were solved to 2.1 Å resolution. Their homodimeric structures exhibit the classic NR α+β fold, with each protomer binding one FMN cofactor near the dimer interface. Functional assays demonstrate that these two NRs metabolize Mtz with associated re-oxidation of the proteins. Importantly, these results represent the first isolation and characterization of NRs from the hypervirulent R20291 strain of relevance to organic RNO2 (e.g., Mtz) metabolism.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FMN cofactor; Metronidazole; Nitroorganic; Nitroreductase; UV–vis; X-ray structure

Mesh:

Substances:

Year:  2016        PMID: 27623089      PMCID: PMC5079799          DOI: 10.1016/j.niox.2016.09.003

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  37 in total

1.  Crystal structure of reduced MsAcg, a putative nitroreductase from Mycobacterium smegmatis and a close homologue of Mycobacterium tuberculosis Acg.

Authors:  François-Xavier Chauviac; Martin Bommer; Jun Yan; Gary Parkin; Tina Daviter; Philip Lowden; Emma L Raven; Konstantinos Thalassinos; Nicholas H Keep
Journal:  J Biol Chem       Date:  2012-11-12       Impact factor: 5.157

2.  Structural and mechanistic studies of Escherichia coli nitroreductase with the antibiotic nitrofurazone. Reversed binding orientations in different redox states of the enzyme.

Authors:  Paul R Race; Andrew L Lovering; Richard M Green; Abdelmijd Ossor; Scott A White; Peter F Searle; Christopher J Wrighton; Eva I Hyde
Journal:  J Biol Chem       Date:  2005-01-31       Impact factor: 5.157

3.  Sequential inactivation of rdxA (HP0954) and frxA (HP0642) nitroreductase genes causes moderate and high-level metronidazole resistance in Helicobacter pylori.

Authors:  J Y Jeong; A K Mukhopadhyay; D Dailidiene; Y Wang; B Velapatiño; R H Gilman; A J Parkinson; G B Nair; B C Wong; S K Lam; R Mistry; I Segal; Y Yuan; H Gao; T Alarcon; M L Brea; Y Ito; D Kersulyte; H K Lee; Y Gong; A Goodwin; P S Hoffman; D E Berg
Journal:  J Bacteriol       Date:  2000-09       Impact factor: 3.490

Review 4.  Reduction of polynitroaromatic compounds: the bacterial nitroreductases.

Authors:  María Dolores Roldán; Eva Pérez-Reinado; Francisco Castillo; Conrado Moreno-Vivián
Journal:  FEMS Microbiol Rev       Date:  2008-03-18       Impact factor: 16.408

5.  Metronidazole resistance in Bacteroides spp. carrying nim genes and the selection of slow-growing metronidazole-resistant mutants.

Authors:  Micaela Gal; J S Brazier
Journal:  J Antimicrob Chemother       Date:  2004-06-09       Impact factor: 5.790

6.  Emergence of reduced susceptibility to metronidazole in Clostridium difficile.

Authors:  Simon D Baines; Rachael O'Connor; Jane Freeman; Warren N Fawley; Celine Harmanus; Paola Mastrantonio; Ed J Kuijper; Mark H Wilcox
Journal:  J Antimicrob Chemother       Date:  2008-08-07       Impact factor: 5.790

Review 7.  Therapies on the horizon for Clostridium difficile infections.

Authors:  Lynne V McFarland
Journal:  Expert Opin Investig Drugs       Date:  2016-03-21       Impact factor: 6.206

Review 8.  In the absence of thioredoxins, what are the reductants for peroxiredoxins in Thermotoga maritima?

Authors:  Jérémy Couturier; Pascalita Prosper; Alison M Winger; Arnaud Hecker; Masakazu Hirasawa; David B Knaff; Pierre Gans; Jean-Pierre Jacquot; Alda Navaza; Ahmed Haouz; Nicolas Rouhier
Journal:  Antioxid Redox Signal       Date:  2012-09-24       Impact factor: 8.401

9.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  1 in total

1.  Evolutionary and molecular foundations of multiple contemporary functions of the nitroreductase superfamily.

Authors:  Eyal Akiva; Janine N Copp; Nobuhiko Tokuriki; Patricia C Babbitt
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-24       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.